Global Synthetic Biology Market to 2025
www.theinsightpartners.com
The synthetic biology market is estimated to grow at a CAGR of 28.2% during the forecast period from 2018 to 2025.
The market for synthetic biology is estimated to reach US$ 56,044.9 Mn in 2025.
Synthetic biology, an interdisciplinary branch of biology and engineering, involves designing and constructing new
devices, systems and biological parts as well as re-designing existing, natural biological systems. It has various
application in the field of food & agriculture, medicine, and other areas. Technologies such as, gene synthesis, genome
engineering and cloning and sequencing help the researchers to understand organization of natural biological systems
and design new biological entities offering various advantages to humans.
In our study, we have segmented the synthetic biology market by product, technology and application. On the basis of
product, the market is segmented into enzymes, oligonucleotides, chassis organisms and xeno-nucleic acids. Enzymes
acquired the largest market among the products due to its wide range of applications in healthcare. On the basis of
technology, the market is segmented into gene synthesis, genome engineering, measurement and modeling, cloning
and sequencing, nanotechnology, and others. Gene synthesis has the largest market share among the technologies
due to an increasing research and development activities in genetics and growing number of market players offering
products and solutions for gene synthesis. On the basis of application, global synthetic biology market is segmented
into industrial applications, food and agriculture, medical applications, environmental applications, and others.
Geographically, the market for synthetic biology is segmented into North America, Europe, Asia Pacific (APC), Middle
East and Africa (MEA) and South and Central America (S&CAM).
The market for synthetic biology is witnessing a potential growth rate during the previous years and is expected to
witness similar trend in the coming years. Global synthetic biology market is driven by extensive use of enzymes kits
and other gene synthesis products in research institutes and academics. Additionally, rising demand for enzyme based
kits and solutions required for gene manipulation and rising awareness about genetic engineering among the
healthcare professionals in developed nations also accelerate the market growth. However, competition among existing
market players may restrain the growth of the market.
In North America, the market is driven by an increasing investment by government organizations and institutes such as
Department of Energy, the National Science Foundation (NSF), Department Of Defense (DoD), the National Institutes of
Health (NIH), and the US Department of Agriculture (USDA). While, Asia Pacific is the fastest growing market driven
increasing investment by private sector companies such as Evolva Biotech Pvt. Ltd and increasing demand for synthetic
biology technologies of industrial and medical applications.
The major players operating in the market of synthetic biology market include ThermoFisher Scientific Inc., Merck KGaA,
Novozymes, Agilent Technologies, Amyris, GenScript, Integrated DNA Technologies, Inc., Twist Bioscience, New England
Biolabs, Synthetic Genomics Inc. and others.
Request Sample Report at https://www.theinsightpartners.com/sample/TIPHE100000960
2